Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Makoto Shinoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3556-2164; OpenAlex author ID A5088393425. Sources: OpenAlex.

Their work

Papers
21 (first author 7, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
58
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: none · 2016: 4 papers · 2017: none · 2018: 2 papers · 2019: none · 2020: 4 papers · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 21

  1. Comparison of supine and upright postures in carbon ion radiotherapy for pancreatic cancer: An in silico planning study. Co-author DOI 10.1002/mp.70325↗
  2. Prognostic Significance of Plasma Soluble IL-6 Receptor in Carbon-ion Radiotherapy for Pancreatic Cancer. First author DOI 10.21873/anticanres.17406↗
  3. Reduced Risk of Severe Radiation-Induced Lymphopenia in Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer: A Comparative Analysis of Carbon V… Co-author DOI 10.1016/j.ijrobp.2024.04.003↗
  4. In Silico Study of Simultaneous Integrated Boost Carbon-Ion Radiotherapy for Locally Advanced Pancreatic Cancer. First author DOI 10.1016/j.ijpt.2024.100585↗
  5. Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis. Co-author DOI 10.1007/s10147-023-02317-x↗
  6. Long-term outcomes of octogenarian pancreatic cancer patients treated with carbon ion radiotherapy. First author DOI 10.1016/j.pan.2022.03.010↗
  7. [Ⅲ. Radiation Therapy for Pancreatic Cancer and Intrahepatic Cholangiocarcinoma, for Which Particle Therapy Is Newly Covered by Public Insurance]. First author PMID 36281597↗
  8. Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy. Co-author DOI 10.1016/j.ctro.2020.10.007↗
  9. Efficacy of Spacers in Radiation Therapy for Locally Advanced Pancreatic Cancer: A Planning Study. Co-author DOI 10.21873/anticanres.14801↗
  10. Carbon ion radiotherapy in pancreatic cancer: A review of clinical data. First author DOI 10.1016/j.radonc.2020.05.012↗
  11. [Ⅱ.Carbon Ion Radiation Therapy as Perioperative Treatment for Pancreatic Cancer]. First author PMID 33130735↗
  12. [Ⅲ.Current Status and Perspective of Heavy-Ion Radiotherapy for Locally Advanced Pancreatic Cancer]. First author PMID 33130736↗
  13. [A Case of Initially Locally Advanced Pancreatic Cancer Curatively Resected after Carbon-Ion Radiotherapy with Gemcitabine]. Co-author PMID 33468929↗
  14. Multi-institutional Study of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 140… Co-author DOI 10.1016/j.ijrobp.2018.04.057↗
  15. A single institutional experience of combined carbon-ion radiotherapy and chemotherapy for unresectable locally advanced pancreatic cancer. Co-author DOI 10.1016/j.radonc.2018.08.026↗
  16. Carbon Ion Radiation Therapy With Concurrent Gemcitabine for Patients With Locally Advanced Pancreatic Cancer. Co-author DOI 10.1016/j.ijrobp.2015.12.362↗
  17. Comparison of carbon-ion passive and scanning irradiation for pancreatic cancer. Co-author DOI 10.1016/j.radonc.2016.04.026↗
  18. Dosimetric analysis of upper gastrointestinal ulcer after carbon-ion radiotherapy for pancreatic cancer. Co-author DOI 10.1016/j.radonc.2016.04.040↗
  19. Prognostic Significance of a Minute Amount of Ascites During Chemoradiotherapy for Locally Advanced Pancreatic Cancer. Co-author PMID 27069174↗
  20. Phase 1 trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer. Co-author DOI 10.1002/cncr.27723↗
  21. Usefulness of 18F-fluorodeoxyglucose positron emission tomography as predictor of distant metastasis in preoperative carbon-ion radiotherapy for pancreatic can… Co-author PMID 24324101↗

Closest collaborators

The 25 strongest of 58 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigeru Yamada · 10 shared papers, 2013–2024 · strength 1.16
  2. Tetsuro Isozaki · 4 shared papers, 2022–2026 · strength 0.98
  3. Taku Inaniwa · 2 shared papers, 2024–2026 · strength 0.57
  4. Yoshiyuki Shioyama · 8 shared papers, 2013–2021 · strength 0.52
  5. Hiroshi Tsuji · 4 shared papers, 2018–2022 · strength 0.51
  6. Shigeru Yamada · 3 shared papers, 2016–2024 · strength 0.49
  7. Taku Nakaji · 1 shared paper, 2024 · strength 0.31
  8. Tapesh Bhattacharyya · 2 shared papers, 2021–2022 · strength 0.28
  9. Tsuguhide Takeshima · 1 shared paper, 2025 · strength 0.28
  10. Takashi Imai · 1 shared paper, 2025 · strength 0.28
  11. Sumitaka Hasegawa · 1 shared paper, 2025 · strength 0.28
  12. Kazutaka Doi · 1 shared paper, 2025 · strength 0.28
  13. Tadashi Kamada · 5 shared papers, 2013–2018 · strength 0.26
  14. Yusuke Nomura · 1 shared paper, 2026 · strength 0.26
  15. Masahiro Jinzaki · 1 shared paper, 2026 · strength 0.26
  16. Gowoon Yang · 1 shared paper, 2024 · strength 0.24
  17. Byung Min Lee · 1 shared paper, 2024 · strength 0.24
  18. Woong Sub Koom · 1 shared paper, 2024 · strength 0.24
  19. Jinsil Seong · 1 shared paper, 2024 · strength 0.24
  20. Hiroshi Honda · 5 shared papers, 2013–2016 · strength 0.23
  21. Shohei Kawashiro · 2 shared papers, 2018–2021 · strength 0.21
  22. Masayuki Otsuka · 2 shared papers, 2016–2020 · strength 0.15
  23. Patrick Naumann · 1 shared paper, 2020 · strength 0.13
  24. Jakob Liermann · 1 shared paper, 2020 · strength 0.13
  25. Klaus K Herfarth · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.